Baudendistel Sidney T, Earhart Gammon M
Program in Physical Therapy, Washington University School of Medicine, St. Louis, USA.
Department of Neurology, Washington University School of Medicine, St. Louis, USA.
Neurodegener Dis Manag. 2025 Aug;15(4):173-186. doi: 10.1080/17582024.2025.2493465. Epub 2025 Apr 30.
The purpose of this review is to identify the characteristics of responders in interventions targeting motor function for individuals with Parkinson disease.
MATERIALS & METHODS: The primary search included, 'Parkinson' + 'responder.' A second, broader, search further included 'response' + 'responsiveness' + 'responsive.' Records were sorted by intervention: neuromodulation, pharmaceutical, physical, and placebo.
Thirteen studies were identified in the primary and 19 studies in the secondary search, culminating in 120 characteristics. For neuromodulation interventions, responders were younger at onset, more responsive to levodopa, and had more difficulties with activities of daily living. Responders to pharmaceuticals were younger at diagnosis. Physical intervention responders had worse balance, less balance confidence, and worse cognition. No relevant characteristics were identified for placebo interventions.
Although there are clear limitations and gaps in the literature, responder analyses represent an important step toward more personalized treatments for the motor symptoms of Parkinson disease.
本综述的目的是确定针对帕金森病患者运动功能干预中反应者的特征。
初步检索包括“帕金森”+“反应者”。第二次更广泛的检索进一步包括“反应”+“反应性”+“反应灵敏的”。记录按干预措施分类:神经调节、药物治疗、物理治疗和安慰剂。
初步检索中识别出13项研究,二次检索中识别出19项研究,最终得出120个特征。对于神经调节干预,反应者发病年龄较轻,对左旋多巴反应更敏感,且日常生活活动有更多困难。药物治疗的反应者诊断时年龄较轻。物理治疗的反应者平衡能力较差,平衡信心较低,认知能力较差。未识别出安慰剂干预的相关特征。
尽管文献存在明显局限性和空白,但反应者分析是朝着帕金森病运动症状更个性化治疗迈出的重要一步。